Position in CELC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,267,444
-$1,025,610 QoQ
Shares Held
98,716
-19.9% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
12 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. CELC ranks #44 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in CELC
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,267,444 | 98,716 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $12,293,054 | 123,251 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,034,049 | 61,418 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,263,426 | 768,796 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,090,991 | 602,472 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $5,853,468 | 447,171 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $4,570,347 | 306,529 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,001,125 | 305,319 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,541,840 | 302,863 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,121,037 | 282,844 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,559,437 | 280,026 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,729,569 | 157,520 | Shares | Defined | 2023-08-14 | |
| No filing history on record for this holder in this stock. | ||||||